IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

SAFC: The Age of the Blockbuster Drug has ‘Disappeared’

9:19 AM MST | November 24, 2008 | Alex Scott

Sigma-Aldrich Fine Chemicals (SAFC), the fastest-growing division within the Sigma-Aldrich group, says it is adapting its business model to the “significantly” changing business environment. A fundamental change is the shift by big pharmaceutical companies away from blockbuster pharma products toward lower-volume, specialty drugs, says Frank Wicks, president of SAFC. Wicks: More flexibility is required. Pharma companies stand to lose $55 billion in sales during the next five years as a slew of drugs go off patent. “The specter of the blockbuster...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa